AIM
TECH icon

Acrospire Investment Management’s Bio-Techne TECH Stock Holding History

Acrospire Investment Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,560
Closed -$46K – 1275
2017
Q2 		$46K Buy
1,560
+800
+105% +$21.9K 0.04% 939
2017
Q1 		$19K Hold
760
– – 0.02% 1661
2016
Q4 		$20K Sell
760
-2,000
-72% -$52.5K 0.01% 1766
2016
Q3 		$76K Buy
2,760
+400
+17% +$11K 0.05% 759
2016
Q2 		$67K Buy
+2,360
New +$60.7K 0.05% 823

Other funds holding TECH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $9.79B AUM 20.6% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acrospire Investment Management's TECH Position: Q3 2017 in Review

Acrospire Investment Management sold out of Bio-Techne (TECH) in Q3 2017, closing a stake of 1,560 shares — an estimated $46K sold.

Acrospire Investment Management first reported a position in TECH in Q2 2016 and held it in 5 quarters. The position peaked at $76K in Q3 2016. 292 funds tracked by Wall St. Rank hold TECH as of Q3 2017.

  • Acrospire Investment Management reported no remaining Bio-Techne position as of Q3 2017 after selling out during the quarter.
  • Acrospire Investment Management sold 1,560 Bio-Techne shares in Q3 2017, an estimated $46K.
  • Acrospire Investment Management first reported a position in Bio-Techne in Q2 2016 and held it in 5 quarters.
  • Acrospire Investment Management's Bio-Techne position peaked at $76K in Q3 2016.
  • 292 funds tracked by Wall St. Rank held Bio-Techne as of Q3 2017.

Based on Acrospire Investment Management's 13F filing for Q3 2017, filed 26 Oct 2017.